Education
About Us
Working with TipRanks
Follow Us
Protagonist Therapeutics (DE:PGF)
BERLIN:PGF
Earnings Data
Report Date
Mar 18, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
―Last Year’s EPS
1.71Same Quarter Last Year
Strong Buy
Based on 13 Analysts Ratings
DE:PGF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:PGF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 06, 2025 | €66.50 | €68.50 | +3.01% |
Aug 06, 2025 | €45.80 | €43.80 | -4.37% |
Apr 30, 2025 | €40.00 | €40.20 | +0.50% |
Feb 21, 2025 | €36.60 | €37.00 | +1.09% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Protagonist Therapeutics (DE:PGF) report earnings?
Protagonist Therapeutics (DE:PGF) is schdueled to report earning on Mar 18, 2026, After Close (Confirmed).
What is Protagonist Therapeutics (DE:PGF) earnings time?
Protagonist Therapeutics (DE:PGF) earnings time is at Mar 18, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Protagonist Therapeutics stock?
The P/E ratio of Protagonist Therapeutics is N/A.
What is DE:PGF EPS forecast?
Currently, no data Available